Reappraisal of eligibility criteria in ...
Type de document :
Article dans une revue scientifique: Article original
PMID :
URL permanente :
Titre :
Reappraisal of eligibility criteria in cancer clinical trials
Auteur(s) :
Penel, Nicolas [Auteur]
METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694
Lebellec, Loic [Auteur]
Université de Lille
Vanseymortier, Marie [Auteur]
Centre Régional de Lutte contre le Cancer Oscar Lambret [Lille] [UNICANCER/Lille]
METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694
Lebellec, Loic [Auteur]
Université de Lille
Vanseymortier, Marie [Auteur]
Centre Régional de Lutte contre le Cancer Oscar Lambret [Lille] [UNICANCER/Lille]
Titre de la revue :
Current opinion in oncology
Nom court de la revue :
Curr Opin Oncol
Numéro :
30
Pagination :
352-357
Éditeur :
Wolters Kluwer
Date de publication :
2018-07-16
ISSN :
1531-703X
Mot(s)-clé(s) en anglais :
cancer clinical trials
generalizability
phase trials
eligibility criteria
participant protection
generalizability
phase trials
eligibility criteria
participant protection
Discipline(s) HAL :
Sciences du Vivant [q-bio]
Résumé en anglais : [en]
We aimed to summarize the recent reflections and collaborative initiatives pertaining to the definition of more appropriate eligibility criteria in cancer clinical trials.
There is an intrinsic tension between two opposite ...
Lire la suite >We aimed to summarize the recent reflections and collaborative initiatives pertaining to the definition of more appropriate eligibility criteria in cancer clinical trials. There is an intrinsic tension between two opposite purposes when it comes to defining eligibility criteria: on the one hand, participants must be protected, and on the other, the study population must be defined as accurately as possible. However, stringent eligibility criteria jeopardize the feasibility of trials, and, consequently, the generalizability of trial results. Therefore, interdisciplinary working groups under the auspices of the American Society of Clinical Oncology and Friends of Cancer Research propose to adapt/relax some of the classical eligibility criteria. In-depth reflection of the existing eligibility criteria, and implementation of recent recommendations are needed.Lire moins >
Lire la suite >We aimed to summarize the recent reflections and collaborative initiatives pertaining to the definition of more appropriate eligibility criteria in cancer clinical trials. There is an intrinsic tension between two opposite purposes when it comes to defining eligibility criteria: on the one hand, participants must be protected, and on the other, the study population must be defined as accurately as possible. However, stringent eligibility criteria jeopardize the feasibility of trials, and, consequently, the generalizability of trial results. Therefore, interdisciplinary working groups under the auspices of the American Society of Clinical Oncology and Friends of Cancer Research propose to adapt/relax some of the classical eligibility criteria. In-depth reflection of the existing eligibility criteria, and implementation of recent recommendations are needed.Lire moins >
Langue :
Anglais
Audience :
Internationale
Vulgarisation :
Non
Établissement(s) :
CHU Lille
Université de Lille
Université de Lille
Date de dépôt :
2019-12-09T18:19:01Z
2024-03-06T11:11:51Z
2024-03-06T11:11:51Z